Remarkably, it has not been assessed whether SGLT-2 inhibitors affect cardiac autonomic function in the acute HF setting and the direct clinical implications, thus, future trials are required to shed further light on those major pathophysiologic mechanisms that have significant prognostic implications in this patients’ population. The gene discussed is SLC5A2; the disease is hydrops fetalis.